Details for New Drug Application (NDA): 214697
✉ Email this page to a colleague
The generic ingredient in NEFFY is epinephrine. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the epinephrine profile page.
Summary for 214697
Tradename: | NEFFY |
Applicant: | Ars Pharms Operation |
Ingredient: | epinephrine |
Patents: | 7 |
Pharmacology for NDA: 214697
Mechanism of Action | Adrenergic alpha-Agonists Adrenergic beta-Agonists |
Medical Subject Heading (MeSH) Categories for 214697
Suppliers and Packaging for NDA: 214697
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NEFFY | epinephrine | SPRAY;NASAL | 214697 | NDA | ARS Pharmaceuticals Operations, Inc. | 82580-020 | 82580-020-02 | 2 BLISTER PACK in 1 CARTON (82580-020-02) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / 100 uL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SPRAY;NASAL | Strength | 2MG/SPRAY | ||||
Approval Date: | Aug 9, 2024 | TE: | RLD: | Yes | |||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 6, 2038 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 6, 2039 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS | ||||||||
Patent: | ⤷ Sign Up | Patent Expiration: | Feb 6, 2038 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | NASAL ADMINISTRATION OF EPINEPHRINE FOR THE TREATMENT OF ALLERGIC REACTIONS (TYPE I), INCLUDING ANAPHYLAXIS |
Complete Access Available with Subscription